WHO-UMC IDMP Management and Publish API, published by Uppsala Monitoring Centre. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/Uppsala-Monitoring-Centre/WHO-UMC-IDMP-Service/ and changes regularly. See the Directory of published versions
<MedicinalProductDefinition xmlns="http://hl7.org/fhir">
<id value="1A0661AE2A40"/>
<meta>
<versionId value="1"/>
<lastUpdated value="2019-05-22T00:52:27.3700941+00:00"/>
<source value="http://idmp.who-umc.org/fhir"/>
<profile
value="http://who-umc.org/idmp/StructureDefinition/MedicinalProductDefinition-who-php-pub"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p class="res-header-id"><b>Generated Narrative: MedicinalProductDefinition 1A0661AE2A40</b></p><a name="1A0661AE2A40"> </a><a name="hc1A0661AE2A40"> </a><a name="1A0661AE2A40-en-US"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">version: 1; Last updated: 2019-05-22 00:52:27+0000; </p><p style="margin-bottom: 0px">Information Source: <a href="http://idmp.who-umc.org/fhir">http://idmp.who-umc.org/fhir</a></p><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-MedicinalProductDefinition-who-php-pub.html">MedicinalProductDefinition for publication</a></p></div><p><b>identifier</b>: <code>http://who-umc.org/idmp/CodeSystem/product</code>/1A0661AE2A40, <code>https://health-products.canada.ca/dpd-bdpp</code>/02182750</p><p><b>type</b>: <span title="Codes:{http://hl7.org/fhir/medicinal-product-type MedicinalProduct}">Medicinal Product</span></p><p><b>domain</b>: <span title="Codes:{http://hl7.org/fhir/medicinal-product-domain Human}">Human use</span></p><p><b>status</b>: <span title="Codes:{http://hl7.org/fhir/publication-status active}">Active</span></p><p><b>combinedPharmaceuticalDoseForm</b>: <span title="Codes:">TABLETS</span></p><p><b>classification</b>: <span title="Codes:{http://who-umc.org/idmp/level4-phpid 91B3CA582581F57E4092F13AAF476215}">91B3CA582581F57E4092F13AAF476215</span></p><h3>Contacts</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Type</b></td><td><b>Contact</b></td></tr><tr><td style="display: none">*</td><td><span title="Codes:{http://hl7.org/fhir/medicinal-product-contact-type ProposedMAH}">Proposed Marketing Authorization Holder/Person</span></td><td><a href="#hc1A0661AE2A40/auropharmainc">Auro Pharma Inc</a></td></tr></table><p><b>code</b>: <a href="CodeSystem-drugcode.html#drugcode-00113802216">WHODrug DrugCode 00113802216</a>: 00113802216</p><blockquote><p><b>name</b></p><p><b>productName</b>: Auro methotrexate</p><h3>Usages</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Country</b></td><td><b>Jurisdiction</b></td><td><b>Language</b></td></tr><tr><td style="display: none">*</td><td><span title="Codes:{urn:iso:std:iso:3166 CAN}">Canada</span></td><td><span title="Codes:{urn:iso:std:iso:3166 CAN}">Canada</span></td><td><span title="Codes:{urn:ietf:bcp:47 en}">English</span></td></tr></table></blockquote><hr/><blockquote><p class="res-header-id"><b>Generated Narrative: Organization #auropharmainc</b></p><a name="1A0661AE2A40/auropharmainc"> </a><a name="hc1A0661AE2A40/auropharmainc"> </a><a name="1A0661AE2A40/auropharmainc-en-US"> </a><p><b>name</b>: Auro Pharma Inc</p></blockquote></div>
</text>
<contained>
<Organization>
<id value="auropharmainc"/>
<name value="Auro Pharma Inc"/>
</Organization>
</contained>
<identifier>
<system value="http://who-umc.org/idmp/CodeSystem/product"/>
<value value="1A0661AE2A40"/>
</identifier>
<identifier>
<system value="https://health-products.canada.ca/dpd-bdpp"/>
<value value="02182750"/>
</identifier>
<type>
<coding>
<system value="http://hl7.org/fhir/medicinal-product-type"/>
<code value="MedicinalProduct"/>
</coding>
</type>
<domain>
<coding>
<system value="http://hl7.org/fhir/medicinal-product-domain"/>
<code value="Human"/>
</coding>
<text value="Human use"/>
</domain>
<status>
<coding>
<system value="http://hl7.org/fhir/publication-status"/>
<code value="active"/>
</coding>
<text value="Active"/>
</status>
<combinedPharmaceuticalDoseForm>
<text value="TABLETS"/>
</combinedPharmaceuticalDoseForm>
<classification>
<coding>
<system value="http://who-umc.org/idmp/level4-phpid"/>
<code value="91B3CA582581F57E4092F13AAF476215"/>
</coding>
</classification>
<contact>
<type>
<coding>
<system value="http://hl7.org/fhir/medicinal-product-contact-type"/>
<code value="ProposedMAH"/>
</coding>
</type>
<contact>
<reference value="#auropharmainc"/>
<type value="Organization"/>
<display value="Auro Pharma Inc"/>
</contact>
</contact>
<code>
<system value="http://who-umc.org/idmp/CodeSystem/drugcode"/>
<code value="00113802216"/>
</code>
<name>
<productName value="Auro methotrexate"/>
<usage>
<country>
<coding>
<system value="urn:iso:std:iso:3166"/>
<code value="CAN"/>
</coding>
</country>
<jurisdiction>
<coding>
<system value="urn:iso:std:iso:3166"/>
<code value="CAN"/>
</coding>
</jurisdiction>
<language>
<coding>
<system value="urn:ietf:bcp:47"/>
<code value="en"/>
</coding>
</language>
</usage>
</name>
</MedicinalProductDefinition>